We look at it as a kind of a new asset class. It really doesn't fit into kind of a broader equity or even global equity kind of asset class because innovation cuts across sectors, geographies, market caps. And so it's providing exposure to a lot of companies that are not held in broader based indices. We're trying to provide that with our portfolios to provide investors and allocators with exposure to artificial intelligence, gene editing, these technologiesthat they otherwise would not have exposure.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode